Recent Patent Ruling Intrudes On Key Antitrust Immunity Doctrine

Legal Backgrounders

November 2, 2001

FTC Improperly Injects Itself Into Drug Patent Settlements

By Geraldine M. Alexis and Zorah Braithwaite, with the law firm McCutchen, Doyle, Brown & Enersen, LLP in its San Francisco office.

Legal Backgrounders

July 13, 2001

Drug Patent Settlements Should Be Handled On A Case By Case Basis

By Jeffrey I. Weinberger, a partner with Munger, Tolles & Olson LLP in Los Angeles, specializing in antitrust and trade regulation matters, and the Chair-Elect of the Antitrust and Unfair Competition Law Section of the State Bar of California.

Working Papers

September 1, 1996

When Intellectual Property And Antitrust Law Collide: FTC Must Tread Lightly

By Robert A. Skitol, a partner with the Washington, D.C. office of Drinker Biddle & Reath.

Leading Legal Scholar John Yoo of UC Berkeley Law Joins WLF’s Legal Policy Advisory Board

FCC v. AT&T; Verizon Communications v. FCC

Growing Exceptions, Shrinking PSLRA Safe Harbor

Legal Backgrounders

Recent Patent Ruling Intrudes On Key Antitrust Immunity Doctrine

FTC Improperly Injects Itself Into Drug Patent Settlements

Drug Patent Settlements Should Be Handled On A Case By Case Basis

When Intellectual Property And Antitrust Law Collide: FTC Must Tread Lightly

Featured

Leading Legal Scholar John Yoo of UC Berkeley Law Joins WLF’s Legal Policy Advisory Board

Featured Case

FCC v. AT&T; Verizon Communications v. FCC

Featured

Growing Exceptions, Shrinking PSLRA Safe Harbor

Legal Backgrounders

Recent Patent Ruling Intrudes On Key Antitrust Immunity Doctrine

Related Content

FTC Improperly Injects Itself Into Drug Patent Settlements

Drug Patent Settlements Should Be Handled On A Case By Case Basis

When Intellectual Property And Antitrust Law Collide: FTC Must Tread Lightly